IIM
RDHL

Ironwood Investment Management’s Redhill Biopharma RDHL Stock Holding History

Ironwood Investment Management’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-39
Closed -$177K – 184
2021
Q3 		$177K Hold
39
– – 0.09% 166
2021
Q2 		$265K Hold
39
– – 0.13% 158
2021
Q1 		$282K Buy
39
+19
+95% +$159K 0.15% 152
2020
Q4 		$164K Sell
20
-7
-26% -$62.9K 0.1% 158
2020
Q3 		$279K Hold
27
– – 0.2% 129
2020
Q2 		$183K Hold
27
– – 0.14% 141
2020
Q1 		$124K Buy
27
+9
+50% +$45K 0.12% 142
2019
Q4 		$110K Hold
18
– – 0.08% 149
2019
Q3 		$128K Buy
+18
New +$131K 0.1% 142

Other funds holding RDHL

DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
II
Ibex Investors Denver, Colorado $152M AUM 19.17% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CAM
Claret Asset Management Montreal, Quebec, Canada $928M AUM 25.4% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Ironwood Investment Management's RDHL Position: Q4 2021 in Review

Ironwood Investment Management sold out of Redhill Biopharma (RDHL) in Q4 2021, closing a stake of 39 shares — an estimated $177K sold.

Ironwood Investment Management first reported a position in RDHL in Q3 2019 and held it in 9 quarters. The position peaked at $282K in Q1 2021. 51 funds tracked by Wall St. Rank hold RDHL as of Q4 2021.

  • Ironwood Investment Management reported no remaining Redhill Biopharma position as of Q4 2021 after selling out during the quarter.
  • Ironwood Investment Management sold 39 Redhill Biopharma shares in Q4 2021, an estimated $177K.
  • Ironwood Investment Management first reported a position in Redhill Biopharma in Q3 2019 and held it in 9 quarters.
  • Ironwood Investment Management's Redhill Biopharma position peaked at $282K in Q1 2021.
  • 51 funds tracked by Wall St. Rank held Redhill Biopharma as of Q4 2021.

Based on Ironwood Investment Management's 13F filing for Q4 2021, filed 10 Feb 2022.